Cas:65195-44-0 [3,3,4,4,5,6,6,6-octafluoro-5-(trifluoromethyl)hexyl] 2-methylprop-2-enoate manufacturer & supplier

Chemical Name:[3,3,4,4,5,6,6,6-octafluoro-5-(trifluoromethyl)hexyl] 2-methylprop-2-enoate

CAS.NO:65195-44-0

Synonyms:pc6103d

Molecular Formula:C₁₁H₉F₁₁O₂

Molecular Weight:382.17000

HS Code:2916140000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:199ºC(lit.)

Density:1.481 g/mL at 25ºC(lit.)

Index of Refraction:n20/D 1.354(lit.)

PSA:26.30000

Exact Mass:382.04300

LogP:4.59930

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like pc6103d chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pc6103d physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pc6103d Use and application,pc6103d technical grade,usp/ep/jp grade.

Related News: The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. [3,3,4,4,5,6,6,6-octafluoro-5-(trifluoromethyl)hexyl] 2-methylprop-2-enoate manufacturer At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content. [3,3,4,4,5,6,6,6-octafluoro-5-(trifluoromethyl)hexyl] 2-methylprop-2-enoate supplier Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities. [3,3,4,4,5,6,6,6-octafluoro-5-(trifluoromethyl)hexyl] 2-methylprop-2-enoate vendor Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities. [3,3,4,4,5,6,6,6-octafluoro-5-(trifluoromethyl)hexyl] 2-methylprop-2-enoate factory The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.